The invention relates to peptides from CPS binding protein,According to the scheme, the sequence of amino acid substitutes (A.A.) was introduced to ensure the enhancement of cell activation capacity dependent on CPS in vitro and in vivo, and to show the benefits of using the substance to improve endocrine disorders, especially endocrine disorders. Systemic inflammation. These peptides are produced by amphibious proteinsHigh density of amino acids and positive and negative charges. The invention determines the exposure of specific amino acids at specific locations in these cucumber sequences to ensure their activity and power. These peptides affect the binding of CPS and LPP, and inhibit the production of human leukemia cells induced by CPS. In addition, these peptides can protect mice allergic to d-activator from the lethal dose of drug resistance. The invention also includes the use of inhibitory peptides and related molecules in the treatment of endocrine related diseases,A pharmaceutical component containing one or more peptides and their derivatives, and a diagnostic method for one or more peptides used in the invention.
展开▼